Cancer survivors are at an elevated risk for infection because of immune suppression associated with prior cancer treatments, and they are at increased risk of complications from vaccine-preventable diseases. This section of the NCCN Guidelines for Survivorship provides recommendations for the prevention of infections in survivors through education, antimicrobial prophylaxis, and the judicious use of vaccines. These guidelines provide information about travel and gardening precautions and safe pet care/avoidance of zoonosis, and include detailed recommendations regarding vaccinations that should be considered and encouraged in cancer and transplant survivors.

  • 1.

    KwonHJLeeJWChungNG. Assessment of serologic immunity to diphtheria-tetanus-pertussis after treatment of Korean pediatric hematology and oncology patients. J Korean Med Sci2012;27:7883.

    • Search Google Scholar
    • Export Citation
  • 2.

    LjungmanPCordonnierCEinseleH. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant2009;44:521526.

  • 3.

    KloskyJLGambleHLSpuntSL. Human papillomavirus vaccination in survivors of childhood cancer. Cancer2009;115:56275636.

  • 4.

    UnderwoodJMTownsendJSStewartSL. Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ2012;61:123.

    • Search Google Scholar
    • Export Citation
  • 5.

    SnyderCFFrickKDPeairsKS. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med2009;24:469474.

    • Search Google Scholar
    • Export Citation
  • 6.

    LocherJLRucksACSpencerSA. Influenza immunization in older adults with and without cancer. J Am Geriatr Soc2012;60:20992103.

  • 7.

    SmallTNZelenetzADNoyA. Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant2009;15:15381542.

    • Search Google Scholar
    • Export Citation
  • 8.

    Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveller. An Advisory Committee Statement (ACS). Can Commun Dis Rep2007;33:124.

    • Search Google Scholar
    • Export Citation
  • 9.

    GradelKONorgaardMDethlefsenC. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study. Ann Hematol2009;88:761767.

    • Search Google Scholar
    • Export Citation
  • 10.

    LortholaryOCharlierCLebeauxD. Fungal infections in immunocompromised travelers. Clin Infect Dis2013;56:861869.

  • 11.

    ManiIMaguireJH. Small animal zoonoses and immuncompromised pet owners. Top Companion Anim Med2009;24:164174.

  • 12.

    Partridge-HinckleyKLiddellGMAlmyroudisNGSegalBH. Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients. Mycopathologia2009;168:329337.

    • Search Google Scholar
    • Export Citation
  • 13.

    VisserLG. The immunosuppressed traveler. Infect Dis Clin North Am2012;26:609624.

  • 14.

    National Center for Immunization and Respiratory Diseases. General recommendations on immunization—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep2011;60:164.

    • Search Google Scholar
    • Export Citation
  • 15.

    BridgesCBCoyne-BeasleyT; Advisory Committee on Immunization Practices. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older: United States, 2014. Ann Intern Med2014;160:190.

    • Search Google Scholar
    • Export Citation
  • 16.

    RubinLGLevinMJLjungmanP. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis2014;58:309318.

    • Search Google Scholar
    • Export Citation
  • 17.

    Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older—United States, 2013. MMWR Surveill Summ2013;62(Suppl 1):1.

    • Search Google Scholar
    • Export Citation
  • 18.

    Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2013*. Ann Intern Med2013;158:191199.

    • Search Google Scholar
    • Export Citation
  • 19.

    Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep2012;61:816819.

    • Search Google Scholar
    • Export Citation
  • 20.

    Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices—United States, 2013-2014. MMWR Recomm Rep2013;62:143.

    • Search Google Scholar
    • Export Citation
  • 21.

    HarpazROrtega-SanchezIRSewardJF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep2008;57:130; quiz CE32-34.

    • Search Google Scholar
    • Export Citation
  • 22.

    WeaverBA; Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention. Update on the advisory committee on immunization practices’ recommendations for use of herpes zoster vaccine. J Am Osteopath Assoc2011;111:S3133.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 84 84 9
PDF Downloads 11 11 0
EPUB Downloads 0 0 0